Unmasking delayed hemolytic transfusion reactions in patients with sickle-cell disease: Challenges and opportunities for improvement
Transfusion
.
2022 Aug;62(8):1662-1670.
doi: 10.1111/trf.16967.
Epub 2022 Jul 2.
Authors
Mischa L Covington
1
,
Jensyn K Cone-Sullivan
2
,
Chester Andrzejewski
3
,
Wen Lu
1
,
Reggie R Thomasson
4
,
Kerry O'Brien
5
,
Patricia A R Brunker
6
,
Sean R Stowell
1
Affiliations
1
Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
2
Department of Pathology and Laboratory Medicine, Tufts Medical Center, Boston, Massachusetts, USA.
3
Transfusion Medicine Service, Baystate Medical Center, Baystate Health, Springfield, Massachusetts, USA.
4
Department of Pathology and Laboratory Medicine, Boston Medical Center and Boston University School of Medicine, Boston, Massachusetts, USA.
5
Department of Pathology, Beth Israel Deaconess, Harvard Medical School, Boston, Massachusetts, USA.
6
Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
PMID:
35778994
DOI:
10.1111/trf.16967
No abstract available
Keywords:
RBC transfusion; blood management; transfusion service operations.
MeSH terms
Anemia, Sickle Cell* / therapy
Humans
Isoantibodies
Transfusion Reaction* / etiology
Substances
Isoantibodies